Study of 1,732 CKD Patients Ties Low Muscle Mass to 28% Higher Death Risk
Updated
Updated · Medscape · Jun 12
Study of 1,732 CKD Patients Ties Low Muscle Mass to 28% Higher Death Risk
1 articles · Updated · Medscape · Jun 12
Summary
Among 1,732 stage 3 CKD patients followed for 5 years, lower muscle mass measured by creatinine muscle index was independently linked to 28% higher all-cause mortality and 23% higher odds of CKD progression.
A higher waist-hip ratio, used as a marker of visceral fat, was independently associated with a 16% higher risk of cardiovascular events over the same period.
Over 5 years, 248 patients died and 605 were hospitalized for cardiovascular events in the cohort, which was recruited from 32 primary care clinics in Derbyshire, England.
The authors said the two low-cost surrogate body-composition measures could improve risk stratification in CKD, though the study did not directly measure muscle mass or visceral adiposity and mainly involved older UK patients.
Beyond BMI, could a simple tape measure predict kidney disease survival?
For millions with kidney disease, is building muscle now more critical than losing weight?
Beyond Weight: Muscle Mass, Sarcopenia, and Evidence-Based Interventions in Chronic Kidney Disease
Overview
Recent medical research is changing how we view body composition in Chronic Kidney Disease (CKD). Instead of just looking at body weight, experts now focus on the balance between muscle mass and fat, as each affects disease progression and survival differently. This shift in thinking is leading to more detailed patient assessments and new management strategies. A major review published in 2026 highlights that maintaining lean muscle mass is crucial for better outcomes in CKD, showing that muscle loss increases the risk of death, regardless of other health factors. This new understanding is shaping future CKD care and guidelines.